Tom Patton

Tom is a seasoned healthcare executive and board member with broad operational, strategic, legal, compliance and transactional experience, from start-ups to growth companies, both public and private.

He last served as Chief Executive Officer of CAS Medical Systems (NASD: CASM), a publicly traded developer and distributor of patient monitoring equipment, from 2010 until its sale to Edwards LifeSciences in 2019. His prior experience includes: Co-Founder, President and CEO of QDX, Inc., a developer of unique micro-fluidic diagnostic technology utilizing digital imaging techniques for hematologic analysis until its sale to Abbott Laboratories; President and Chief Operating Officer of Novametrix Medical Systems, Inc. (NASD: NMTX) until its sale to Respironics; and CEO of Wright Medical Technology, Inc. until its sale to Warburg Pincus. Tom has also served as Advisor to Ferrer Freeman & Company, a healthcare focused private equity fund manager.

Over the years, Mr. Patton has served on twelve Boards of Directors for both public and private medical products and services companies, and currently serves on the Board of Misonix (NASD: MSON), a publicly traded ultrasonic surgical tools and wound care company, and ElectroCore (NASD: ECOR) a provider of non-invasive vagal nerve stimulation products to address various patient conditions.

Tom started his career as a litigator at the renowned law firm of Williams and Connolly in Washington DC before joining Wright Medical as its General Counsel in 1993. He graduated from The College of the Holy Cross and magna cum laude from Georgetown University Law Center.